title: Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
abstract: OBJECTIVE
  To assess the activity and toxicity of the combination of gemcitabine plus dacarbazine (DTIC) in patients with advanced soft tissue sarcoma (STS) in a randomized, multicenter, phase II study using DTIC alone as a control arm.
  
  
  METHODS
  Patients with previously treated advanced STS were randomly assigned to receive either fixed-dose rate gemcitabine (10 mg/m2/min) at 1800 mg/m2 followed by DTIC at 500 mg/m2 every 2 weeks, or DTIC alone at 1200 mg/m2 every 3 weeks. The primary end point of the study was progression-free rate (PFR) at 3 months.
  
  
  RESULTS
  From November 2005 to September 2008, 113 patients were included. PFR at 3 months was 56% for gemcitabine plus DTIC versus 37% for DTIC alone (P = .001). Median progression-free survival was 4.2 months versus 2 months (hazard ratio [HR], 0.58; 95% CI, 0.39 to 0.86; P = .005), and median overall survival was 16.8 months versus 8.2 months (HR, 0.56; 95% CI, 0.36 to 0.90; P = .014); both favored the arm of gemcitabine plus DTIC. Gemcitabine plus DTIC was also associated with a higher objective response or higher stable disease rate than was DTIC alone (49% v 25%; P = .009). Severe toxicities were uncommon, and treatment discontinuation for toxicity was rare. Granulocytopenia was the more common serious adverse event, but febrile neutropenia was uncommon. Asthenia, emesis, and stomatitis were the most frequent nonhematologic effects.
  
  
  CONCLUSIONS
  The combination of gemcitabine and DTIC is active and well tolerated in patients with STS, providing in this phase II randomized trial superior progression-free survival and overall survival than DTIC alone. This regimen constitutes a valuable therapeutic alternative for these patients.
authors: Sarcoma Multidisciplinary Unit, Institut Català d'Oncologia L'Hospitalet, Avda Gran Via Km 2.7. 08907 L'Hospitalet. Barcelona, Spain. garciadelmuro@iconcologia.net
authors: Xavier
authors: X
authors: García-Del-Muro
authors: Antonio
authors: A
authors: López-Pousa
authors: Joan
authors: J
authors: Maurel
authors: Javier
authors: J
authors: Martín
authors: Javier
authors: J
authors: Martínez-Trufero
authors: Antonio
authors: A
authors: Casado
authors: Auxiliadora
authors: A
authors: Gómez-España
authors: Joaquín
authors: J
authors: Fra
authors: Josefina
authors: J
authors: Cruz
authors: Andrés
authors: A
authors: Poveda
authors: Andrés
authors: A
authors: Meana
authors: Carlos
authors: C
authors: Pericay
authors: Ricardo
authors: R
authors: Cubedo
authors: Jordi
authors: J
authors: Rubió
authors: Ana
authors: A
authors: De Juan
authors: Nuria
authors: N
authors: Laínez
authors: Juan Antonio
authors: JA
authors: Carrasco
authors: Raquel
authors: R
authors: de Andrés
authors: José M
authors: JM
authors: Buesa